Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Selma Curkic Kapidzic, Johan Gustafsson, Erik Larsson, Lovisa Jessen & Katarina Sjögreen Gleisner. (2024) Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs. Physica Medica 120, pages 103335.
Crossref
Crossref
Gefei Chen, Zhonglin Lu, Han Jiang, Ali Afshar-Oromieh, Axel Rominger, Kuangyu Shi & Greta S. P. Mok. (2023) Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points. Frontiers in Medicine 10.
Crossref
Crossref
Johan Gustafsson & Jan Taprogge. (2023) Future trends for patient-specific dosimetry methodology in molecular radiotherapy. Physica Medica 115, pages 103165.
Crossref
Crossref
Amit Nautiyal, Sofia Michopoulou & Matt Guy. (2023) Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review. Clinical and Translational Imaging 12:2, pages 157-175.
Crossref
Crossref
Typhanie Ladrière, Julie Faudemer, Elise Levigoureux, Damien Peyronnet, Cédric Desmonts & Jonathan Vigne. (2023) Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals. Pharmaceutics 15:4, pages 1240.
Crossref
Crossref
Oscar Ardenfors, Joachim N. Nilsson, Daniel Thor & Cecilia Hindorf. (2022) Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy. EJNMMI Physics 9:1.
Crossref
Crossref
Javian C. Malcolm, Nadia Falzone, Jennifer E. Gains, Matthew D. Aldridge, David Mirando, Boon Q. Lee, Mark N. Gaze & Katherine A. Vallis. (2022) Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE. EJNMMI Physics 9:1.
Crossref
Crossref
Hanna Piwowarska-Bilska, Sara Kurkowska & Bozena Birkenfeld. (2022) Individualization of Radionuclide Therapies: Challenges and Prospects. Cancers 14:14, pages 3418.
Crossref
Crossref
John Kennedy, Alexandre Chicheportiche & Zohar Keidar. (2022) Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy. Seminars in Nuclear Medicine 52:2, pages 229-242.
Crossref
Crossref
Johan Gustafsson & Jan Taprogge. (2022) Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy. Physics in Medicine & Biology 67:2, pages 025003.
Crossref
Crossref
Peter Frøhlich Staanum, Anders Floor Frellsen, Marie Louise Olesen, Peter Iversen & Anne Kirstine Arveschoug. (2021) Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates. EJNMMI Physics 8:1.
Crossref
Crossref
Carlo Chiesa, Lidia Strigari, Massimiliano Pacilio, Elisa Richetta, Vittorio Cannatà, Michele Stasi, Maria Cristina Marzola, Orazio Schillaci, Oreste Bagni & Marco Maccauro. (2021) Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN). Physica Medica 89, pages 317-326.
Crossref
Crossref
Theresa P. Devasia, Yuni K. Dewaraja, Kirk A. Frey, Ka Kit Wong & Matthew J. Schipper. (2021)
A Novel Time–Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After
177
Lu-DOTATATE
. Journal of Nuclear Medicine 62:8, pages 1118-1125.
Crossref
Crossref
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler & Arman Rahmim. (2021) Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies. Journal of Nuclear Medicine 62:7, pages 1006-1011.
Crossref
Crossref
T. Monserrat Fuertes, F.M. González García, M.Á. Peinado Montes, M.L. Domínguez Grande, N. Martín Fernández, A. Gómez de Iturriaga Piña & P. Mínguez Gabiña. (2021) Description of the methodology for dosimetric quantification in treatments with 177Lu-DOTATATE. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 40:3, pages 167-178.
Crossref
Crossref
T. Monserrat Fuertes, F.M. González García, M.Á. Peinado Montes, M.L. Domínguez Grande, N. Martín Fernández, A. Gómez de Iturriaga Piña & P. Mínguez Gabiña. (2021) Descripción de la metodología para la cuantificación dosimétrica en tratamientos con 177Lu-DOTATATE. Revista Española de Medicina Nuclear e Imagen Molecular 40:3, pages 167-178.
Crossref
Crossref
Alexandre Chicheportiche, Simona Ben-Haim, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David J. Gross & Jeremy Godefroy. (2020) Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management. EJNMMI Physics 7:1.
Crossref
Crossref
Erick Mora‐Ramirez, Lore Santoro, Emmanuelle Cassol, Juan C. Ocampo‐Ramos, Naomi Clayton, Gunjan Kayal, Soufiane Chouaf, Dorian Trauchessec, Jean‐Pierre Pouget, Pierre‐Olivier Kotzki, Emmanuel Deshayes & Manuel Bardiès. (2020)
Comparison of commercial dosimetric software platforms in patients treated with
177
Lu‐DOTATATE for peptide receptor radionuclide therapy
. Medical Physics 47:9, pages 4602-4615.
Crossref
Crossref
V. Habouzit, P. Tylski, A. Deville & C. Bournaud. (2020) Dosimétrie rénale du 177Lu-Dotatate : mise en place au sein du Groupement hospitalier Est des Hospices Civils de Lyon. Médecine Nucléaire 44:3, pages 203-212.
Crossref
Crossref
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, H. Carlo Maurer, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Götz-Ulrich Grigoleit, Ulrich Keller & Constantin Lapa. (2019) Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation. Journal of Nuclear Medicine 60:10, pages 1399-1405.
Crossref
Crossref
Xinchi Hou, Wei Zhao, Jean-Mathieu Beauregard & Anna Celler. (2019)
Personalized kidney dosimetry in
177
Lu-octreotate treatment of neuroendocrine tumours: a comparison of kidney dosimetry estimates based on a whole organ and small volume segmentations
. Physics in Medicine & Biology 64:17, pages 175004.
Crossref
Crossref
Wei Zhao, Pedro Luis Esquinas, Andrea Frezza, Xinchi Hou, Jean-Mathieu Beauregard & Anna Celler. (2019)
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
177
Lu-DOTATATE patient study
. Physics in Medicine & Biology 64:17, pages 175006.
Crossref
Crossref
Marcelo Tatit Sapienza & José Willegaignon. (2019) Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning. Clinics 74, pages e835.
Crossref
Crossref
Kathy P. Willowson, Enid Eslick, Hyunju Ryu, Aurora Poon, Elizabeth J. Bernard & Dale L. Bailey. (2018) Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy. EJNMMI Physics 5:1.
Crossref
Crossref
Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès & Emmanuel Deshayes. (2018) Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate. EJNMMI Research 8:1.
Crossref
Crossref
Lucy F. Matthews & Ivor W. Jones. (2018) The effect of kidney volume estimation on dosimetry in lutetium-177 DOTATATE therapy. Nuclear Medicine Communications 39:6, pages 527-532.
Crossref
Crossref
Heribert Hänscheid, Constantin Lapa, Andreas K. Buck, Michael Lassmann & Rudolf A. Werner. (2018)
Dose Mapping After Endoradiotherapy with
177
Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days
. Journal of Nuclear Medicine 59:1, pages 75-81.
Crossref
Crossref
Eero T. Hippeläinen, Mikko J. Tenhunen, Hanna O. Mäenpää, Jorma J. Heikkonen & Antti O. Sohlberg. (2017) Dosimetry software Hermes Internal Radiation Dosimetry. Nuclear Medicine Communications 38:5, pages 357-365.
Crossref
Crossref
Heribert Hänscheid, Constantin Lapa, Andreas Buck, Michael Lassmann & Rudolf Werner. (2018) Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOC. Nuklearmedizin 56:06, pages 219-224.
Crossref
Crossref
Keamogetswe Ramonaheng, Johan A. van Staden & Hanlie du Raan. (2021) Accuracy of Two Dosimetry Software Programs for <sup>177</sup>Lu Radiopharmaceutical Therapy Using Voxel-Based Patient-Specific Phantoms. SSRN Electronic Journal.
Crossref
Crossref